{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:04:51Z","timestamp":1777910691498,"version":"3.51.4"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T00:00:00Z","timestamp":1376611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072709","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T21:05:09Z","timestamp":1376687109000},"page":"e72709","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Interferon-\u03b2 Produces Synergistic Combinatory Anti-Tumor Effects with Cisplatin or Pemetrexed on Mesothelioma Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Quanhai","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Shingyouji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,8,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30227","article-title":"The pathogenesis of mesothelioma","volume":"29","author":"M Carbone","year":"2002","journal-title":"Semin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"BW Robinson","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"NJ Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/cncr.22552","article-title":"Update on the molecular biology of malignant mesothelioma","volume":"109","author":"AY Lee","year":"2007","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/cgt.2011.86","article-title":"Upregulated p53 expression activates apoptotic pathways in wild-type <italic>p53<\/italic>-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed","volume":"19","author":"Q Li","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.2008.00698.x","article-title":"Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha\/beta, IFN-gamma, and IFN-lambda in host defense","volume":"226","author":"SY Zhang","year":"2008","journal-title":"Immunol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1189\/jlb.1208761","article-title":"Interferon-\u03bbs: the modulators of antivirus, antitumor, and immune responses","volume":"86","author":"M Li","year":"2009","journal-title":"J Leukoc Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2012.03.006","article-title":"Pharmacology and therapeutic potential of interferons","volume":"135","author":"PM George","year":"2012","journal-title":"Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/1097-0142(20010801)92:3<650::AID-CNCR1366>3.0.CO;2-0","article-title":"Combined regimen of cisplatin, doxorubicin, and alpha-2\u03b2 interferon in the treatment of advanced malignant pleural mesothelioma: a phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)","volume":"92","author":"HS Parra","year":"2001","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/sj.bjc.6690597","article-title":"High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma","volume":"80","author":"M Halme","year":"1999","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1378\/chest.116.2.391","article-title":"Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma","volume":"116","author":"M Metintas","year":"1999","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1158\/1078-0432.CCR-07-0403","article-title":"A phase I clinical trial of single-dose intrapleural IFN-\u03b2 gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses","volume":"13","author":"DH Sterman","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1164\/rccm.201103-0554CR","article-title":"A trial of intrapleural adenoviral-mediated Interferon-{alpha}2b gene transfer for malignant pleural mesothelioma","volume":"184","author":"DH Sterman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01850","article-title":"Integration of interferon-\u03b1\/\u03b2 signalling to p53 responses in tumour suppression and antiviral defence","volume":"424","author":"A Takaoka","year":"2003","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/sj.onc.1208403","article-title":"TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells","volume":"24","author":"S Vannucchi","year":"2005","journal-title":"Oncogene"},{"key":"ref16","first-page":"979","article-title":"Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma","volume":"134","author":"Y Ke","year":"1989","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejca.2009.10.002","article-title":"Interferon-\u03bb induces G1 phase arrest or apoptosis in esophageal carcinoma cells and produces anti-tumor effects in combination with anti-cancer agents","volume":"46","author":"Q Li","year":"2010","journal-title":"Eur J Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/sj.onc.1208618","article-title":"Cyclins and cdks in development and cancer: a perspective","volume":"24","author":"A Deshpande","year":"2005","journal-title":"Oncogene"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1038\/onc.2009.170","article-title":"Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms","volume":"28","author":"A Satyanarayana","year":"2009","journal-title":"Oncogene"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/j.1349-7006.2011.02079.x","article-title":"Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer","volume":"102","author":"H Fujie","year":"2011","journal-title":"Cancer Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"20053","DOI":"10.1074\/jbc.R700006200","article-title":"Type I interferon receptors: biochemistry and biological functions","volume":"282","author":"NA de Weerd","year":"2007","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1038\/sj.onc.1202609","article-title":"Molecular mechanisms underlying interferon-alpha-induced G0\/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins","volume":"18","author":"O Sangfelt","year":"1999","journal-title":"Oncogene"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/jir.2005.25.799","article-title":"Alternative signaling pathways regulating type I interferon-induced apoptosis","volume":"25","author":"K Pokrovskaja","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"ref24","first-page":"2114","article-title":"The impact of p53 status on cellular sensitivity to antifolate drugs","volume":"7","author":"X Lu","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bjc.6603639","article-title":"Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels","volume":"96","author":"E Giovannetti","year":"2007","journal-title":"Br J Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mc.21842","article-title":"Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated\/p53-dependent and -independent signaling pathways","volume":"52","author":"TY Yang","year":"2013","journal-title":"Mol Carcinog"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"32275","DOI":"10.1074\/jbc.M313830200","article-title":"Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines","volume":"279","author":"R Sandoval","year":"2004","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ctrv.2011.01.001","article-title":"Advances in the biology of malignant pleural mesothelioma","volume":"37","author":"PA Zucali","year":"2011","journal-title":"Cancer Treat Rev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T11:27:46Z","timestamp":1540034866000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072709"}},"subtitle":[],"editor":[{"given":"Fabrizio","family":"Mattei","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,16]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072709","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,16]]}}}